[go: up one dir, main page]

DE602004003965D1 - Halogenalkyl- und piperidinsubstituierte benzimidazolderivate - Google Patents

Halogenalkyl- und piperidinsubstituierte benzimidazolderivate

Info

Publication number
DE602004003965D1
DE602004003965D1 DE602004003965T DE602004003965T DE602004003965D1 DE 602004003965 D1 DE602004003965 D1 DE 602004003965D1 DE 602004003965 T DE602004003965 T DE 602004003965T DE 602004003965 T DE602004003965 T DE 602004003965T DE 602004003965 D1 DE602004003965 D1 DE 602004003965D1
Authority
DE
Germany
Prior art keywords
halogenal
cyl
benzimidazole derivatives
substituted benzimidazole
piperidine substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004003965T
Other languages
English (en)
Other versions
DE602004003965T2 (de
Inventor
Ralf Anderskewitz
Domnic Martyres
Horst Dollinger
Pascale Pouzet
Franz Birke
Thierry Bouyssou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Publication of DE602004003965D1 publication Critical patent/DE602004003965D1/de
Application granted granted Critical
Publication of DE602004003965T2 publication Critical patent/DE602004003965T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/63Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
    • C04B35/632Organic additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Ceramic Engineering (AREA)
  • Rheumatology (AREA)
  • Manufacturing & Machinery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE602004003965T 2003-08-25 2004-08-19 Halogenalkyl- und piperidinsubstituierte benzimidazolderivate Expired - Lifetime DE602004003965T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03018705 2003-08-25
EP03018705 2003-08-25
PCT/EP2004/009292 WO2005019203A1 (en) 2003-08-25 2004-08-19 Haloalkyl- and piperidine-substituted benzimidazole-derivatives

Publications (2)

Publication Number Publication Date
DE602004003965D1 true DE602004003965D1 (de) 2007-02-08
DE602004003965T2 DE602004003965T2 (de) 2007-04-26

Family

ID=34203215

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004003965T Expired - Lifetime DE602004003965T2 (de) 2003-08-25 2004-08-19 Halogenalkyl- und piperidinsubstituierte benzimidazolderivate

Country Status (11)

Country Link
EP (1) EP1660476B1 (de)
JP (1) JP4783286B2 (de)
AR (1) AR045491A1 (de)
AT (1) ATE349441T1 (de)
CA (1) CA2536787C (de)
DE (1) DE602004003965T2 (de)
ES (1) ES2279423T3 (de)
PE (1) PE20050369A1 (de)
TW (1) TW200514778A (de)
UY (1) UY28490A1 (de)
WO (1) WO2005019203A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7759365B2 (en) 2005-04-30 2010-07-20 Boehringer Ingelheim International Gmbh Piperidine-substituted indoles
AU2006314264B2 (en) * 2005-11-15 2012-07-19 Latchways Plc. Safety device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB0005642D0 (en) * 2000-03-10 2000-05-03 Astrazeneca Uk Ltd Chemical compounds

Also Published As

Publication number Publication date
UY28490A1 (es) 2005-03-31
TW200514778A (en) 2005-05-01
DE602004003965T2 (de) 2007-04-26
EP1660476B1 (de) 2006-12-27
CA2536787C (en) 2012-02-21
ATE349441T1 (de) 2007-01-15
CA2536787A1 (en) 2005-03-03
AR045491A1 (es) 2005-11-02
WO2005019203A1 (en) 2005-03-03
EP1660476A1 (de) 2006-05-31
PE20050369A1 (es) 2005-06-24
ES2279423T3 (es) 2007-08-16
JP4783286B2 (ja) 2011-09-28
JP2007503411A (ja) 2007-02-22

Similar Documents

Publication Publication Date Title
DK1515969T3 (da) Spiroindolinpiperidinderivater
IS7667A (is) Nýjar bensimídazólafleiður
NO20054224D0 (no) Nye 2-pyridinkarboksamidderivater
ATE460418T1 (de) Heterocyclocarboxamidderivate
DK1551802T3 (da) Indol-3-svovlderivater
ATE467631T1 (de) Chinuclidinamidderivate
ATE438644T1 (de) Chinazolinderivate
DK1474408T3 (da) N-Phenyl-2-pyrimidinaminderivater
ATE308543T1 (de) Piperidinderivate
ATE386518T1 (de) Benzimidazolderivate
ATE420066T1 (de) Amidoacetonitrilderivate
DK1626964T3 (da) Nye benzimidazolderivater
DK1606277T3 (da) Imidazol-4-yl-ethynyl-pyridinderivater
DK1675852T3 (da) Heterocykliske 7-amino-alkylidenyl-quinoloner og -naphthyridoner
ATE335729T1 (de) 3h-chinazoline -4-on derivaten
DK1682129T3 (da) N-thiazol-2-ylbenzamidderivater
ATE423771T1 (de) Tetrahydrochinolinderivate
DK1706373T3 (da) Amidoacetonitrilderivater
IS8045A (is) Púrín-6-ón-afleiður
DE50306277D1 (de) 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate
DE602004003965D1 (de) Halogenalkyl- und piperidinsubstituierte benzimidazolderivate
ATE285408T1 (de) Paroxetin-n-formyl-derivate
IS8182A (is) Díarýlmetýlídenpíperídínafleiður, blöndur og notkun þeirra
DE50311730D1 (de) Fredericamycin-derivate
ATE395327T1 (de) Amidoacetonitrilderivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition